Company intelligence / Profile preview

Futurelife

Prague, Czech Republic

Ownership: Private
Employees: ~1500
Development stage: Other

Overview

FutureLife is a leading European healthcare provider specializing in assisted reproduction (IVF) and genetic testing services. Founded in 2013 and headquartered in Prague, the company operates an extensive network of over 40 clinics across the Czech Republic, United Kingdom, Ireland, Netherlands, and other European markets. FutureLife provides a full spectrum of fertility treatments, including egg and sperm donation, cryopreservation, and advanced laboratory diagnostics. The group is backed by CVC Capital Partners and Hartenberg Holding, following a major investment in 2022 to drive further international expansion and consolidation of the fragmented fertility market.

Therapeutic areas: Rare DiseasesWomen's Health
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Futurelife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Futurelife.

Explore the full profile